Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.449, 2004-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ciprofloxacin ER value for money in uncomplicated UTIs
Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. :
Access to resources
Recommend
Extended-release ciprofloxacin a more convenient option for UTIs
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :
Amantadine `value for money' for influenza in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 367, 2002-01 ,pp. :
Bevacizumab "best value for money" in MCRC . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. :